Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Matcheri S Keshavan1, John Torous1

  • 1Harvard Medical School.

Schizophrenia Research
|May 19, 2019
PubMed
Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Engagement with the national electronic health records by people with Parkinson's disease.

Frontiers in aging neuroscience·2026
Same author

Specialized or General-Purpose-The Wrong Question for Mental Health AI Safety.

JAMA·2026
Same author

Clinician's Corner: Chatbots for Psychotherapy.

Canadian journal of psychiatry. Revue canadienne de psychiatrie·2026
Same author

A New CMS Payment Model for AI-Delivered Behavioral Health Care.

JAMA psychiatry·2026
Same author

Leveraging simulation to provide a practical framework for estimating the novel scope of risk of large language models in healthcare.

BMJ mental health·2026
Same author

Transparency Over Gatekeeping.

The American journal of bioethics : AJOB·2026
Same journal

Quality evaluation of randomized controlled trials of antipsychotic drugs for schizophrenia published in Chinese journals.

Schizophrenia research·2026
Same journal

FL-SDGIN: A federated graph learning approach for schizophrenia diagnosis integrating static and dynamic brain functional networks.

Schizophrenia research·2026
Same journal

Weight loss and gut microbial changes associated with semaglutide among people living with schizophrenia receiving clozapine or olanzapine: An open-label 24-week semaglutide intervention and 76-week trial.

Schizophrenia research·2026
Same journal

Converting negative symptom dimension scores across SANS and PANSS.

Schizophrenia research·2026
Same journal

Inflammation-associated alterations in mGluR transcript expression in the human nucleus accumbens independent of schizophrenia diagnosis.

Schizophrenia research·2026
Same journal

One social interaction after another: Dynamic modeling of social experience in schizophrenia.

Schizophrenia research·2026
See all related articles